Kevin Feeley - 30 Sep 2025 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Reporting relationship: CHIEF FINANCIAL OFFICER
Issuer ticker: WGS
Reported as of: 30 Sep 2025
Net transaction value: -$675,554
SEC form: 4
Accepted by SEC: 01 Oct 2025, 16:18:24 UTC
Prior SEC filing: 18 Sep 2025
Next SEC filing: 31 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/ Bridget Brown, Attorney-in-Fact

Key filing fact

Kevin Feeley filed Form 4 for GeneDx Holdings Corp. (WGS) on 01 Oct 2025.

Key facts

This page summarizes Kevin Feeley's Form 4 filing for GeneDx Holdings Corp. (WGS).
9 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 01 Oct 2025, 16:18.

Change

Previous filing in this sequence was filed on 18 Sep 2025.
Current net transaction value: -$675,554.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001944119 Primary reporting owner

Feeley Kevin

Relationship: CHIEF FINANCIAL OFFICER
Address: C/O GENEDX HOLDINGS CORP., STAMFORD
Signature: /s/ Bridget Brown, Attorney-in-Fact
Signature date: 01 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WGS transaction

Class A Common Stock

Options Exercise

Transaction value: $40,707
Shares: +1,246
Change %: +14%
Price: $32.67
Shares after: 10,001
Date: 30 Sep 2025
Ownership: Direct
Footnotes: F1

WGS transaction

Class A Common Stock

Sale

Transaction value: $36,203
Shares: -344
Change %: -3.4%
Price: $105.24
Shares after: 9,657
Date: 30 Sep 2025
Ownership: Direct
Footnotes: F1, F2

WGS transaction

Class A Common Stock

Sale

Transaction value: $41,354
Shares: -387
Change %: -4%
Price: $106.86
Shares after: 9,270
Date: 30 Sep 2025
Ownership: Direct
Footnotes: F1, F3

WGS transaction

Class A Common Stock

Sale

Transaction value: $292,361
Shares: -2,715
Change %: -29%
Price: $107.68
Shares after: 6,555
Date: 30 Sep 2025
Ownership: Direct
Footnotes: F1, F4

WGS transaction

Class A Common Stock

Sale

Transaction value: $233,851
Shares: -2,152
Change %: -33%
Price: $108.67
Shares after: 4,403
Date: 30 Sep 2025
Ownership: Direct
Footnotes: F1, F5

WGS transaction

Class A Common Stock

Sale

Transaction value: $46,330
Shares: -421
Change %: -9.6%
Price: $110.05
Shares after: 3,982
Date: 30 Sep 2025
Ownership: Direct
Footnotes: F1, F6

WGS transaction

Class A Common Stock

Sale

Transaction value: $58,204
Shares: -520
Change %: -13%
Price: $111.93
Shares after: 3,462
Date: 30 Sep 2025
Ownership: Direct
Footnotes: F1, F7

WGS transaction

Class A Common Stock

Sale

Transaction value: $7,958
Shares: -70
Change %: -2%
Price: $113.68
Shares after: 3,392
Date: 30 Sep 2025
Ownership: Direct
Footnotes: F1, F8

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

WGS transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -1,246
Change %: -20%
Price: $0.000000
Shares after: 4,982
Date: 30 Sep 2025
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 1,246
Exercise price: $32.67
Footnotes: F1, F9

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 9 footnotes

Footnote F1

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.98 to $105.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 7.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.1354 to $107.01, inclusive.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.22 to $108.20, inclusive.

Footnote F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.23 to $109.1754, inclusive.

Footnote F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.3225 to $110.25, inclusive.

Footnote F7

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.50 to $112.04, inclusive.

Footnote F8

Following the reported sales effectuated pursuant to a 10b5-1 plan, in addition to the 3,392 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 124,633 shares of Class A common stock and options to purchase up to an aggregate of 25,906 shares of Class A common stock, which RSUs and options vest according to their respective terms.

Footnote F9

The award vested or vests as to 6.25% of the total award quarterly over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.